Serum and urine levels of tamoxifen and its metabolites in patients with advanced breast cancer after a loading dose and at steady-state levels

Cancer Chemother Pharmacol. 1998;42(6):512-4. doi: 10.1007/s002800050854.

Abstract

Purpose: To compare serum and urine levels of tamoxifen and metabolites after a loading dose and at the steady state.

Methods: A loading dose of 160 mg of tamoxifen was given to 14 patients with advanced breast cancer. Thereafter a regular daily dose of 30 mg of tamoxifen was given. Serum and urine levels of tamoxifen and metabolites were measured by high-performance liquid chromatography and compared with levels determined in 31 patients with advanced breast cancer at the steady state at a daily dose of 30 mg of tamoxifen.

Results: Serum and urine levels (24-h values) of tamoxifen and metabolites were lower (P < 0.05) after a loading dose than at the steady state. The difference was most pronounced for the metabolites, whereas the tamoxifen loading-dose level was near the steady state.

Conclusion: Tamoxifen steady state can be reached in 1-2 days by the administration of a loading dose of 160 mg of tamoxifen for 2 days. Tamoxifen metabolite steady-state levels are reached regularly after 4 or more weeks during application of a loading dose. Very little tamoxifen or metabolites are excreted into the urine.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents, Hormonal / administration & dosage
  • Antineoplastic Agents, Hormonal / blood
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Antineoplastic Agents, Hormonal / urine
  • Breast Neoplasms / blood
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / urine
  • Drug Administration Schedule
  • Humans
  • Middle Aged
  • Tamoxifen / administration & dosage
  • Tamoxifen / blood
  • Tamoxifen / therapeutic use*
  • Tamoxifen / urine

Substances

  • Antineoplastic Agents, Hormonal
  • Tamoxifen